EUVIMEDEUVIMED entdecken
Open Access

Neuronal and Glial Metabolite Abnormalities in Participants With Persistent Neuropsychiatric Symptoms After COVID-19: A Brain Proton Magnetic Resonance Spectroscopy Study

Thomas Ernst, Meghann C Ryan, Hua-Jun Liang, Justin P Wang, Eric Cunningham, Muhammad G Saleh, Shyamasundaran Kottilil, Linda Chang

The Journal of Infectious Diseases · 2023

DOI: 10.1093/infdis/jiad309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Thomas Ernst und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Radiology and Nuclear Medicine, School of Medicine, University of Maryland. Hauptthemen laut MEDLINE: Glutamine, COVID-19. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The aim of this study was to determine whether neurometabolite abnormalities indicating neuroinflammation and neuronal injury are detectable in individuals post–coronavirus disease 2019 (COVID-19) with persistent neuropsychiatric symptoms.

Methods

All participants were studied with proton magnetic resonance spectroscopy at 3 T to assess neurometabolite concentrations (point-resolved spectroscopy, relaxation time/echo time = 3000/30 ms) in frontal white matter (FWM) and anterior cingulate cortex–gray matter (ACC-GM). Participants also completed the National Institutes of Health Toolbox cognition and motor batteries and selected modules from the Patient-Reported Outcomes Measurement Information System.

Results

Fifty-four participants were evaluated: 29 post–COVID-19 (mean ± SD age, 42.4 ± 12.3 years; approximately 8 months from COVID-19 diagnosis; 19 women) and 25 controls (age, 44.1 ± 12.3 years; 14 women). When compared with controls, the post–COVID-19 group had lower total N-acetyl compounds (tNAA; ACC-GM: −5.0%, P = .015; FWM: –4.4%, P = .13), FWM glutamate + glutamine (–9.5%, P = .001), and ACC-GM myo-inositol (−6.2%, P = .024). Additionally, only hospitalized patients post–COVID-19 showed age-related increases in myo-inositol, choline compounds, and total creatine (interaction P = .029 to <.001). Across all participants, lower FWM tNAA and higher ACC-GM myo-inositol predicted poorer performance on several cognitive measures (P = .001–.009), while lower ACC-GM tNAA predicted lower endurance on the 2-minute walk (P = .005).

Conclusions

In participants post–COVID-19 with persistent neuropsychiatric symptoms, the lower-than-normal tNAA and glutamate + glutamine indicate neuronal injury, while the lower-than-normal myo-inositol reflects glial dysfunction, possibly related to mitochondrial dysfunction and oxidative stress in Post-COVID participants with persistent neuropsychiatric symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlutamineCOVID-19HumansFemaleAdultMiddle AgedProton Magnetic Resonance SpectroscopyProtonsCOVID-19 TestingBrainInositolGlutamatesAspartic Acid

Stichwörter der Autor:innen

COVID-19N-acetylaspartatemyo-inositolneuropsychiatric symptomsproton magnetic resonance spectroscopy

Substanzen

GlutamineProtonsInositolGlutamatesAspartic Acid

Autor:innen und Institutionen

  • Department of Diagnostic Radiology and Nuclear Medicine, School of Medicine, University of Maryland.
  • Department of Neurology, School of Medicine, Johns Hopkins University.
  • Program in Neuroscience, School of Medicine, University of Maryland.
  • Institute of Human Virology, Division of Infectious Disease, Department of Medicine, School of Medicine, University of Maryland.
  • Department of Neurology, School of Medicine, University of Maryland, Baltimore.

Förderung

  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Ernst, T., Ryan, M. C., Liang, H. J., Wang, J. P., Cunningham, E., Saleh, M. G., Kottilil, S., & Chang, L. (2023). Neuronal and Glial Metabolite Abnormalities in Participants With Persistent Neuropsychiatric Symptoms After COVID-19: A Brain Proton Magnetic Resonance Spectroscopy Study. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad309

Vancouver

Ernst T, Ryan MC, Liang HJ, Wang JP, Cunningham E, Saleh MG, et al. Neuronal and Glial Metabolite Abnormalities in Participants With Persistent Neuropsychiatric Symptoms After COVID-19: A Brain Proton Magnetic Resonance Spectroscopy Study. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiad309

BibTeX
@article{Ernst2023,
  author = {Ernst, Thomas and Ryan, Meghann C and Liang, Hua-Jun and Wang, Justin P and Cunningham, Eric and Saleh, Muhammad G and Kottilil, Shyamasundaran and Chang, Linda},
  title = {Neuronal and Glial Metabolite Abnormalities in Participants With Persistent Neuropsychiatric Symptoms After COVID-19: A Brain Proton Magnetic Resonance Spectroscopy Study},
  journal = {The Journal of Infectious Diseases},
  year = {2023},
  doi = {10.1093/infdis/jiad309}
}
Kostenlos starten →